Genomma Lab stock holds at MXN 12.36

Published on 09/21/2026 at 18:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genomma Lab stock traded at MXN 12.36 on September 21, 2026, unchanged on the session. Reuters showed the Mexican group at 52-week range data on the same day.

Genomma Lab, MXP4693Q1093, Illustration mit AI erstellt.

Genomma Lab stock (ISIN MXP4693Q1093) traded at MXN 12.36 on September 21, 2026, unchanged on the session. Reuters showed the Mexican group at that level, while the company remains a consumer health name for retail investors tracking Mexico-listed stocks.

Price and range

The same Reuters quote placed the shares at MXN 12.36 with a 0.00 percent daily change on September 21, 2026. That gives investors one clear anchor for the session.

The company has a market profile that still matters more than headlines on a thin day. Genomma Lab's listed equity was shown at MXN 12.36, with the date stamp visible in Reuters market data from September 21, 2026.

What the numbers say

The most recent fundamental line in the available material is the company's reported 2025 net income of MXN 2.70 billion, versus MXN 2.05 billion in 2024, a rise of 31.7 percent. That comparison is historical, but it gives a concrete base for the current valuation debate.

Genomma Lab also reported 2025 revenue of MXN 17.43 billion, up from MXN 16.03 billion a year earlier, and EBITDA of MXN 4.70 billion for 2025. For investors, the margin trend is the key number: EBITDA represented 27.0 percent of revenue in that year.

Investor takeaway

The shares therefore sit near a clean price reference while the last full-year figures still show stronger profitability than the prior period. On September 21, 2026, the stock stood at MXN 12.36 in Reuters market data, with no other dated market value needed to read the session.